BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 36974785)

  • 21. New nomogram predicts the recurrence of hepatocellular carcinoma in patients with negative preoperative serum AFP subjected to curative resection.
    Gan W; Huang JL; Zhang MX; Fu YP; Yi Y; Jing CY; Fan J; Zhou J; Qiu SJ
    J Surg Oncol; 2018 Jun; 117(7):1540-1547. PubMed ID: 29572833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic Significance of Preoperative Controlling Nutritional Status (CONUT) Score in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma: A Multi-institutional Study.
    Harimoto N; Yoshizumi T; Inokuchi S; Itoh S; Adachi E; Ikeda Y; Uchiyama H; Utsunomiya T; Kajiyama K; Kimura K; Kishihara F; Sugimachi K; Tsujita E; Ninomiya M; Fukuzawa K; Maeda T; Shirabe K; Maehara Y
    Ann Surg Oncol; 2018 Oct; 25(11):3316-3323. PubMed ID: 30051372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term outcomes of repeat hepatic resection in patients with recurrent hepatocellular carcinoma and analysis of recurrent types and their prognosis: a single-center experience in China.
    Huang ZY; Liang BY; Xiong M; Zhan DQ; Wei S; Wang GP; Chen YF; Chen XP
    Ann Surg Oncol; 2012 Aug; 19(8):2515-25. PubMed ID: 22395985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Defining the chance of cure after resection for hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guidelines: A multi-institutional analysis of 1,010 patients.
    Tsilimigras DI; Bagante F; Moris D; Merath K; Paredes AZ; Sahara K; Ratti F; Marques HP; Soubrane O; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Pawlik TM
    Surgery; 2019 Dec; 166(6):967-974. PubMed ID: 31606196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perioperative blood transfusion and survival following curative hepatic resection for hepatocellular carcinoma.
    Hanazaki K; Kajikawa S; Shimozawa N; Matsushita A; Machida T; Shimada K; Yazawa K; Koide N; Adachi W; Amano J
    Hepatogastroenterology; 2005; 52(62):524-9. PubMed ID: 15816471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical relevance of alpha-fetoprotein in determining resection margin for hepatocellular carcinoma.
    Lee JC; Cheng CH; Wang YC; Wu TH; Lee CF; Wu TJ; Chou HS; Chan KM; Lee WC
    Medicine (Baltimore); 2019 Mar; 98(11):e14827. PubMed ID: 30882667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive model for microvascular invasion of hepatocellular carcinoma among candidates for either hepatic resection or liver transplantation.
    Nitta H; Allard MA; Sebagh M; Karam V; Ciacio O; Pittau G; Vibert E; Sa Cunha A; Cherqui D; Castaing D; Bismuth H; Guettier C; Samuel D; Baba H; Adam R
    Surgery; 2019 Jun; 165(6):1168-1175. PubMed ID: 30878140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prognostic model and treatment strategy for intrahepatic recurrence of hepatocellular carcinoma after curative resection.
    Umeda Y; Matsuda H; Sadamori H; Matsukawa H; Yagi T; Fujiwara T
    World J Surg; 2011 Jan; 35(1):170-7. PubMed ID: 20922387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
    Liu C; Sun L; Xu J; Zhao Y
    World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of prognostic factors on recurrence after curative resections for hepatocellular carcinoma.
    Han JH; Kim DG; Na GH; Kim EY; Lee SH; Hong TH; You YK
    World J Gastroenterol; 2014 Dec; 20(45):17132-40. PubMed ID: 25493027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-Term Outcome After Resection of Huge Hepatocellular Carcinoma ≥ 10 cm: Single-Institution Experience with 471 Patients.
    Hwang S; Lee YJ; Kim KH; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Lee SG
    World J Surg; 2015 Oct; 39(10):2519-28. PubMed ID: 26126423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Des-gamma-carboxy prothrombin and alpha-fetoprotein positive status as a new prognostic indicator after hepatic resection for hepatocellular carcinoma.
    Shimada M; Takenaka K; Fujiwara Y; Gion T; Kajiyama K; Maeda T; Shirabe K; Sugimachi K
    Cancer; 1996 Nov; 78(10):2094-100. PubMed ID: 8918402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma.
    Hashimoto K; Ikeda Y; Korenaga D; Tanoue K; Hamatake M; Kawasaki K; Yamaoka T; Iwatani Y; Akazawa K; Takenaka K
    Cancer; 2005 May; 103(9):1856-64. PubMed ID: 15779015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic markers affecting the early recurrence of hepatocellular carcinoma with liver cirrhosis after curative resection.
    Kim WJ; Lim TW; Park PJ; Choi SB; Kim WB
    Int J Biol Markers; 2019 Jun; 34(2):123-131. PubMed ID: 30977422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Poor oncologic outcomes of hepatocellular carcinoma patients with intra-abdominal infection after hepatectomy.
    Ruan DY; Lin ZX; Li Y; Jiang N; Li X; Wu DH; Wang TT; Chen J; Lin Q; Wu XY
    World J Gastroenterol; 2015 May; 21(18):5598-606. PubMed ID: 25987785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the risk factors for early death due to disease recurrence or progression within 1 year after hepatectomy in patients with hepatocellular carcinoma.
    Kamiyama T; Nakanishi K; Yokoo H; Kamachi H; Tahara M; Kakisaka T; Tsuruga Y; Todo S; Taketomi A
    World J Surg Oncol; 2012 Jun; 10():107. PubMed ID: 22697061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors influencing hepatocellular carcinoma prognosis after hepatectomy: a single-center experience.
    Park SK; Jung YK; Chung DH; Kim KK; Park YH; Lee JN; Kwon OS; Kim YS; Choi DJ; Kim JH
    Korean J Intern Med; 2013 Jul; 28(4):428-38. PubMed ID: 23864801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatic resection versus operative microwave ablation for single hepatocellular carcinoma ≤5 cm: A propensity score-matched analysis.
    Ryu T; Takami Y; Wada Y; Hara T; Sasaki S; Saitsu H
    Surgery; 2019 Sep; 166(3):254-262. PubMed ID: 31279438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors of long-term survival and recurrence after curative resection of hepatocellular carcinoma.
    Hanazaki K; Matsushita A; Nakagawa K; Misawa R; Amano J
    Hepatogastroenterology; 2005; 52(62):552-7. PubMed ID: 15816476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic resection for hepatocellular carcinoma in diameter of > or = 10 cm.
    Hanazaki K; Kajikawa S; Shimozawa N; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J
    Hepatogastroenterology; 2002; 49(44):518-23. PubMed ID: 11995486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.